학술논문

Simulated treatment comparison of efficacy outcomes for ofatumumab in ASCLEPIOS I/II versus ocrelizumab in OPERA I/II for the treatment of patients with relapsing multiple sclerosis
Document Type
Article
Source
In: Multiple Sclerosis and Related Disorders. (Multiple Sclerosis and Related Disorders, October 2022, 66)
Subject
Language
English
ISSN
22110356
22110348